Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas
Washington University School of Medicine
Washington University School of Medicine
Fred Hutchinson Cancer Center
University College, London
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)